MedPath

Case management after acquired brain injury

Completed
Conditions
niet aangeboren hersenletsel
ABI
acquired brain injury
Registration Number
NL-OMON49157
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
209
Inclusion Criteria

Inclusion criteria for patients:
* Acquired brain injury objectified by medical specialist (see appendix for
diagnosis and medical codes)
* Aged 18 years or older
* Living in the community prior to the injury
* Discharged home after hospital/rehabilitation
* Sufficient command of the Dutch language
* Access to a computer and the internet (monitoring tool and questionnaires)
* Willing and able to give informed consent

Exclusion Criteria

A potential subject will be excluded from participation in this study when they
have degenerative disorders (e.g. Parkinson*s disease, dementia) because of the
progressive course of the disease. Patients with a diagnosis related to
neuro-oncology will be excluded as well, since an intensive care trajectory is
already in place for these patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Hospital Anxiety and Depression Scale (HADS)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The effectiveness will be evaluated by assessment of self-management (Patient<br /><br>Activation Measure (PAM)), psychosocial well-being (Utrecht Scale for<br /><br>Evaluation of Rehabilitation-Participation (USER-P) restriction subscale, the<br /><br>Life Satisfaction Questionnaire (LiSat) and care needs (Longer-term Unmet<br /><br>Needs after Stroke (LUNS)) and service use (care consumption list). Caregiver<br /><br>outcomes include self-efficacy (Carer Self-Efficacy Scale (CSES)), caregiver<br /><br>burden (Caregiver Strain Index (CSI)), psychosocial well-being (LiSat, HADS),<br /><br>caregiver needs (Family Needs Questionnaire (FNQ)).<br /><br><br /><br>The feasibility will be evaluated using registration by caseamangers and<br /><br>patients/caregivers.<br /><br><br /><br>The costeneffectiveness is measured with a specific costquestionnaire and the<br /><br>EQ-5D-5L.</p><br>
© Copyright 2025. All Rights Reserved by MedPath